CN112480220A - Random recombinant mutant protein of Sip1Aa protein of bacillus thuringiensis - Google Patents
Random recombinant mutant protein of Sip1Aa protein of bacillus thuringiensis Download PDFInfo
- Publication number
- CN112480220A CN112480220A CN202011390510.6A CN202011390510A CN112480220A CN 112480220 A CN112480220 A CN 112480220A CN 202011390510 A CN202011390510 A CN 202011390510A CN 112480220 A CN112480220 A CN 112480220A
- Authority
- CN
- China
- Prior art keywords
- thr
- protein
- lys
- asn
- ser
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 62
- 102000004169 proteins and genes Human genes 0.000 title abstract description 45
- 241000193388 Bacillus thuringiensis Species 0.000 title abstract description 14
- 229940097012 bacillus thuringiensis Drugs 0.000 title abstract description 14
- 102000008300 Mutant Proteins Human genes 0.000 title abstract description 10
- 108010021466 Mutant Proteins Proteins 0.000 title abstract description 10
- 241000607479 Yersinia pestis Species 0.000 claims abstract description 6
- 241000254173 Coleoptera Species 0.000 claims description 16
- 239000002773 nucleotide Substances 0.000 claims description 8
- 125000003729 nucleotide group Chemical group 0.000 claims description 8
- 239000002917 insecticide Substances 0.000 claims description 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 230000000749 insecticidal effect Effects 0.000 abstract description 29
- 150000001413 amino acids Chemical class 0.000 abstract description 11
- 241000894006 Bacteria Species 0.000 abstract description 3
- 101000619564 Homo sapiens Putative testis-specific prion protein Proteins 0.000 abstract description 2
- 102100022208 Putative testis-specific prion protein Human genes 0.000 abstract description 2
- 231100000086 high toxicity Toxicity 0.000 abstract description 2
- 206010059866 Drug resistance Diseases 0.000 abstract 1
- 230000001934 delay Effects 0.000 abstract 1
- 230000009261 transgenic effect Effects 0.000 abstract 1
- 230000035772 mutation Effects 0.000 description 41
- 235000018102 proteins Nutrition 0.000 description 37
- 239000013612 plasmid Substances 0.000 description 28
- 238000006243 chemical reaction Methods 0.000 description 22
- 239000000499 gel Substances 0.000 description 18
- 239000000047 product Substances 0.000 description 18
- 230000003321 amplification Effects 0.000 description 17
- 238000003199 nucleic acid amplification method Methods 0.000 description 17
- 230000000694 effects Effects 0.000 description 11
- 238000001976 enzyme digestion Methods 0.000 description 10
- 229910052739 hydrogen Inorganic materials 0.000 description 10
- 239000001257 hydrogen Substances 0.000 description 10
- 238000005215 recombination Methods 0.000 description 9
- 238000011084 recovery Methods 0.000 description 9
- 241000588724 Escherichia coli Species 0.000 description 8
- 238000012408 PCR amplification Methods 0.000 description 8
- 230000006798 recombination Effects 0.000 description 8
- 238000011160 research Methods 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 241000238631 Hexapoda Species 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 108020004414 DNA Proteins 0.000 description 6
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 6
- XSEPSRUDSPHMPX-KATARQTJSA-N Thr-Lys-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O XSEPSRUDSPHMPX-KATARQTJSA-N 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 108010092854 aspartyllysine Proteins 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 108010034529 leucyl-lysine Proteins 0.000 description 6
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 5
- 229960000723 ampicillin Drugs 0.000 description 5
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 5
- 238000001962 electrophoresis Methods 0.000 description 5
- 230000036438 mutation frequency Effects 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 238000003753 real-time PCR Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 4
- YLTKNGYYPIWKHZ-ACZMJKKPSA-N Ala-Ala-Glu Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O YLTKNGYYPIWKHZ-ACZMJKKPSA-N 0.000 description 3
- YWWATNIVMOCSAV-UBHSHLNASA-N Ala-Arg-Phe Chemical compound NC(=N)NCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 YWWATNIVMOCSAV-UBHSHLNASA-N 0.000 description 3
- BGNLUHXLSAQYRQ-FXQIFTODSA-N Ala-Glu-Gln Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O BGNLUHXLSAQYRQ-FXQIFTODSA-N 0.000 description 3
- PUBLUECXJRHTBK-ACZMJKKPSA-N Ala-Glu-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O PUBLUECXJRHTBK-ACZMJKKPSA-N 0.000 description 3
- NCQMBSJGJMYKCK-ZLUOBGJFSA-N Ala-Ser-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O NCQMBSJGJMYKCK-ZLUOBGJFSA-N 0.000 description 3
- DHONNEYAZPNGSG-UBHSHLNASA-N Ala-Val-Phe Chemical compound C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 DHONNEYAZPNGSG-UBHSHLNASA-N 0.000 description 3
- OTOXOKCIIQLMFH-KZVJFYERSA-N Arg-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N OTOXOKCIIQLMFH-KZVJFYERSA-N 0.000 description 3
- UFBURHXMKFQVLM-CIUDSAMLSA-N Arg-Glu-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O UFBURHXMKFQVLM-CIUDSAMLSA-N 0.000 description 3
- RIQBRKVTFBWEDY-RHYQMDGZSA-N Arg-Lys-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O RIQBRKVTFBWEDY-RHYQMDGZSA-N 0.000 description 3
- NIELFHOLFTUZME-HJWJTTGWSA-N Arg-Phe-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O NIELFHOLFTUZME-HJWJTTGWSA-N 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 3
- XWGJDUSDTRPQRK-ZLUOBGJFSA-N Asn-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O XWGJDUSDTRPQRK-ZLUOBGJFSA-N 0.000 description 3
- AYZAWXAPBAYCHO-CIUDSAMLSA-N Asn-Asn-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)N AYZAWXAPBAYCHO-CIUDSAMLSA-N 0.000 description 3
- IICZCLFBILYRCU-WHFBIAKZSA-N Asn-Gly-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IICZCLFBILYRCU-WHFBIAKZSA-N 0.000 description 3
- HYQYLOSCICEYTR-YUMQZZPRSA-N Asn-Gly-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O HYQYLOSCICEYTR-YUMQZZPRSA-N 0.000 description 3
- YGHCVNQOZZMHRZ-DJFWLOJKSA-N Asn-His-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC(=O)N)N YGHCVNQOZZMHRZ-DJFWLOJKSA-N 0.000 description 3
- HCZQKHSRYHCPSD-IUKAMOBKSA-N Asn-Thr-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HCZQKHSRYHCPSD-IUKAMOBKSA-N 0.000 description 3
- QIRJQYQOIKBPBZ-IHRRRGAJSA-N Asn-Tyr-Arg Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QIRJQYQOIKBPBZ-IHRRRGAJSA-N 0.000 description 3
- CNKAZIGBGQIHLL-GUBZILKMSA-N Asp-Arg-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N CNKAZIGBGQIHLL-GUBZILKMSA-N 0.000 description 3
- CJUKAWUWBZCTDQ-SRVKXCTJSA-N Asp-Leu-Lys Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O CJUKAWUWBZCTDQ-SRVKXCTJSA-N 0.000 description 3
- NONWUQAWAANERO-BZSNNMDCSA-N Asp-Phe-Tyr Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 NONWUQAWAANERO-BZSNNMDCSA-N 0.000 description 3
- DRCOAZZDQRCGGP-GHCJXIJMSA-N Asp-Ser-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O DRCOAZZDQRCGGP-GHCJXIJMSA-N 0.000 description 3
- ZQFRDAZBTSFGGW-SRVKXCTJSA-N Asp-Ser-Phe Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ZQFRDAZBTSFGGW-SRVKXCTJSA-N 0.000 description 3
- KBJVTFWQWXCYCQ-IUKAMOBKSA-N Asp-Thr-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KBJVTFWQWXCYCQ-IUKAMOBKSA-N 0.000 description 3
- BPAUXFVCSYQDQX-JRQIVUDYSA-N Asp-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC(=O)O)N)O BPAUXFVCSYQDQX-JRQIVUDYSA-N 0.000 description 3
- LPYPANUXJGFMGV-FXQIFTODSA-N Gln-Gln-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)N)N LPYPANUXJGFMGV-FXQIFTODSA-N 0.000 description 3
- ZQPOVSJFBBETHQ-CIUDSAMLSA-N Gln-Glu-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O ZQPOVSJFBBETHQ-CIUDSAMLSA-N 0.000 description 3
- XJKAKYXMFHUIHT-AUTRQRHGSA-N Gln-Glu-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)N)N XJKAKYXMFHUIHT-AUTRQRHGSA-N 0.000 description 3
- CAXXTYYGFYTBPV-IUCAKERBSA-N Gln-Leu-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O CAXXTYYGFYTBPV-IUCAKERBSA-N 0.000 description 3
- IOFDDSNZJDIGPB-GVXVVHGQSA-N Gln-Leu-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O IOFDDSNZJDIGPB-GVXVVHGQSA-N 0.000 description 3
- ILKYYKRAULNYMS-JYJNAYRXSA-N Gln-Lys-Phe Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ILKYYKRAULNYMS-JYJNAYRXSA-N 0.000 description 3
- UXXIVIQGOODKQC-NUMRIWBASA-N Gln-Thr-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O UXXIVIQGOODKQC-NUMRIWBASA-N 0.000 description 3
- INGJLBQKTRJLFO-UKJIMTQDSA-N Glu-Ile-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCC(O)=O INGJLBQKTRJLFO-UKJIMTQDSA-N 0.000 description 3
- JWNZHMSRZXXGTM-XKBZYTNZSA-N Glu-Ser-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JWNZHMSRZXXGTM-XKBZYTNZSA-N 0.000 description 3
- JVYNYWXHZWVJEF-NUMRIWBASA-N Glu-Thr-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O JVYNYWXHZWVJEF-NUMRIWBASA-N 0.000 description 3
- BRFJMRSRMOMIMU-WHFBIAKZSA-N Gly-Ala-Asn Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O BRFJMRSRMOMIMU-WHFBIAKZSA-N 0.000 description 3
- XRTDOIOIBMAXCT-NKWVEPMBSA-N Gly-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)CN)C(=O)O XRTDOIOIBMAXCT-NKWVEPMBSA-N 0.000 description 3
- FZQLXNIMCPJVJE-YUMQZZPRSA-N Gly-Asp-Leu Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O FZQLXNIMCPJVJE-YUMQZZPRSA-N 0.000 description 3
- WDEHMRNSGHVNOH-VHSXEESVSA-N Gly-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)CN)C(=O)O WDEHMRNSGHVNOH-VHSXEESVSA-N 0.000 description 3
- CQMFNTVQVLQRLT-JHEQGTHGSA-N Gly-Thr-Gln Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O CQMFNTVQVLQRLT-JHEQGTHGSA-N 0.000 description 3
- FNXSYBOHALPRHV-ONGXEEELSA-N Gly-Val-Lys Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCCN FNXSYBOHALPRHV-ONGXEEELSA-N 0.000 description 3
- RVKIPWVMZANZLI-UHFFFAOYSA-N H-Lys-Trp-OH Natural products C1=CC=C2C(CC(NC(=O)C(N)CCCCN)C(O)=O)=CNC2=C1 RVKIPWVMZANZLI-UHFFFAOYSA-N 0.000 description 3
- IPYVXYDYLHVWHU-GMOBBJLQSA-N Ile-Asn-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCSC)C(=O)O)N IPYVXYDYLHVWHU-GMOBBJLQSA-N 0.000 description 3
- NKRJALPCDNXULF-BYULHYEWSA-N Ile-Asp-Gly Chemical compound [H]N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O NKRJALPCDNXULF-BYULHYEWSA-N 0.000 description 3
- QSPLUJGYOPZINY-ZPFDUUQYSA-N Ile-Asp-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N QSPLUJGYOPZINY-ZPFDUUQYSA-N 0.000 description 3
- GYAFMRQGWHXMII-IUKAMOBKSA-N Ile-Asp-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N GYAFMRQGWHXMII-IUKAMOBKSA-N 0.000 description 3
- WZDCVAWMBUNDDY-KBIXCLLPSA-N Ile-Glu-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)O)N WZDCVAWMBUNDDY-KBIXCLLPSA-N 0.000 description 3
- JZNVOBUNTWNZPW-GHCJXIJMSA-N Ile-Ser-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O)N JZNVOBUNTWNZPW-GHCJXIJMSA-N 0.000 description 3
- ZNOBVZFCHNHKHA-KBIXCLLPSA-N Ile-Ser-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N ZNOBVZFCHNHKHA-KBIXCLLPSA-N 0.000 description 3
- ANTFEOSJMAUGIB-KNZXXDILSA-N Ile-Thr-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@@H]1C(=O)O)N ANTFEOSJMAUGIB-KNZXXDILSA-N 0.000 description 3
- NSPNUMNLZNOPAQ-SJWGOKEGSA-N Ile-Tyr-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N2CCC[C@@H]2C(=O)O)N NSPNUMNLZNOPAQ-SJWGOKEGSA-N 0.000 description 3
- VCSBGUACOYUIGD-CIUDSAMLSA-N Leu-Asn-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O VCSBGUACOYUIGD-CIUDSAMLSA-N 0.000 description 3
- WMIOEVKKYIMVKI-DCAQKATOSA-N Leu-Pro-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O WMIOEVKKYIMVKI-DCAQKATOSA-N 0.000 description 3
- SBANPBVRHYIMRR-UHFFFAOYSA-N Leu-Ser-Pro Natural products CC(C)CC(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O SBANPBVRHYIMRR-UHFFFAOYSA-N 0.000 description 3
- BRTVHXHCUSXYRI-CIUDSAMLSA-N Leu-Ser-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O BRTVHXHCUSXYRI-CIUDSAMLSA-N 0.000 description 3
- AEDWWMMHUGYIFD-HJGDQZAQSA-N Leu-Thr-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O AEDWWMMHUGYIFD-HJGDQZAQSA-N 0.000 description 3
- 102000003960 Ligases Human genes 0.000 description 3
- 108090000364 Ligases Proteins 0.000 description 3
- KPJJOZUXFOLGMQ-CIUDSAMLSA-N Lys-Asp-Asn Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N KPJJOZUXFOLGMQ-CIUDSAMLSA-N 0.000 description 3
- HIIZIQUUHIXUJY-GUBZILKMSA-N Lys-Asp-Gln Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O HIIZIQUUHIXUJY-GUBZILKMSA-N 0.000 description 3
- XFBBBRDEQIPGNR-KATARQTJSA-N Lys-Cys-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)N)O XFBBBRDEQIPGNR-KATARQTJSA-N 0.000 description 3
- WTZUSCUIVPVCRH-SRVKXCTJSA-N Lys-Gln-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N WTZUSCUIVPVCRH-SRVKXCTJSA-N 0.000 description 3
- NNKLKUUGESXCBS-KBPBESRZSA-N Lys-Gly-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O NNKLKUUGESXCBS-KBPBESRZSA-N 0.000 description 3
- ZXFRGTAIIZHNHG-AJNGGQMLSA-N Lys-Ile-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCCCN)N ZXFRGTAIIZHNHG-AJNGGQMLSA-N 0.000 description 3
- OIQSIMFSVLLWBX-VOAKCMCISA-N Lys-Leu-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OIQSIMFSVLLWBX-VOAKCMCISA-N 0.000 description 3
- LUAJJLPHUXPQLH-KKUMJFAQSA-N Lys-Phe-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCCCN)N LUAJJLPHUXPQLH-KKUMJFAQSA-N 0.000 description 3
- UDXSLGLHFUBRRM-OEAJRASXSA-N Lys-Phe-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N)O UDXSLGLHFUBRRM-OEAJRASXSA-N 0.000 description 3
- JHNOXVASMSXSNB-WEDXCCLWSA-N Lys-Thr-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O JHNOXVASMSXSNB-WEDXCCLWSA-N 0.000 description 3
- GILLQRYAWOMHED-DCAQKATOSA-N Lys-Val-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCCN GILLQRYAWOMHED-DCAQKATOSA-N 0.000 description 3
- IKXQOBUBZSOWDY-AVGNSLFASA-N Lys-Val-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CCCCN)N IKXQOBUBZSOWDY-AVGNSLFASA-N 0.000 description 3
- FVKRQMQQFGBXHV-QXEWZRGKSA-N Met-Asp-Val Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O FVKRQMQQFGBXHV-QXEWZRGKSA-N 0.000 description 3
- MYAPQOBHGWJZOM-UWVGGRQHSA-N Met-Gly-Leu Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(C)C MYAPQOBHGWJZOM-UWVGGRQHSA-N 0.000 description 3
- QGRJTULYDZUBAY-ZPFDUUQYSA-N Met-Ile-Glu Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O QGRJTULYDZUBAY-ZPFDUUQYSA-N 0.000 description 3
- HWROAFGWPQUPTE-OSUNSFLBSA-N Met-Ile-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](CCSC)N HWROAFGWPQUPTE-OSUNSFLBSA-N 0.000 description 3
- LCPUWQLULVXROY-RHYQMDGZSA-N Met-Lys-Thr Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LCPUWQLULVXROY-RHYQMDGZSA-N 0.000 description 3
- AOFZWWDTTJLHOU-ULQDDVLXSA-N Met-Lys-Tyr Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 AOFZWWDTTJLHOU-ULQDDVLXSA-N 0.000 description 3
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 3
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 3
- AJHCSUXXECOXOY-UHFFFAOYSA-N N-glycyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-UHFFFAOYSA-N 0.000 description 3
- HCTXJGRYAACKOB-SRVKXCTJSA-N Phe-Asn-Asp Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N HCTXJGRYAACKOB-SRVKXCTJSA-N 0.000 description 3
- BPIMVBKDLSBKIJ-FCLVOEFKSA-N Phe-Thr-Phe Chemical compound C([C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 BPIMVBKDLSBKIJ-FCLVOEFKSA-N 0.000 description 3
- IWNOFCGBMSFTBC-CIUDSAMLSA-N Pro-Ala-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O IWNOFCGBMSFTBC-CIUDSAMLSA-N 0.000 description 3
- AMBLXEMWFARNNQ-DCAQKATOSA-N Pro-Asn-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@@H]1CCCN1 AMBLXEMWFARNNQ-DCAQKATOSA-N 0.000 description 3
- QDDJNKWPTJHROJ-UFYCRDLUSA-N Pro-Tyr-Tyr Chemical compound C([C@@H](C(=O)O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H]1NCCC1)C1=CC=C(O)C=C1 QDDJNKWPTJHROJ-UFYCRDLUSA-N 0.000 description 3
- QPFJSHSJFIYDJZ-GHCJXIJMSA-N Ser-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CO QPFJSHSJFIYDJZ-GHCJXIJMSA-N 0.000 description 3
- BPMRXBZYPGYPJN-WHFBIAKZSA-N Ser-Gly-Asn Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O BPMRXBZYPGYPJN-WHFBIAKZSA-N 0.000 description 3
- BKZYBLLIBOBOOW-GHCJXIJMSA-N Ser-Ile-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(O)=O BKZYBLLIBOBOOW-GHCJXIJMSA-N 0.000 description 3
- VAIWUNAAPZZGRI-IHPCNDPISA-N Ser-Trp-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CO)N VAIWUNAAPZZGRI-IHPCNDPISA-N 0.000 description 3
- SIEBDTCABMZCLF-XGEHTFHBSA-N Ser-Val-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SIEBDTCABMZCLF-XGEHTFHBSA-N 0.000 description 3
- CTONFVDJYCAMQM-IUKAMOBKSA-N Thr-Asn-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)O)N CTONFVDJYCAMQM-IUKAMOBKSA-N 0.000 description 3
- LAFLAXHTDVNVEL-WDCWCFNPSA-N Thr-Gln-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O)N)O LAFLAXHTDVNVEL-WDCWCFNPSA-N 0.000 description 3
- KBBRNEDOYWMIJP-KYNKHSRBSA-N Thr-Gly-Thr Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)O)N)O KBBRNEDOYWMIJP-KYNKHSRBSA-N 0.000 description 3
- YOOAQCZYZHGUAZ-KATARQTJSA-N Thr-Leu-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YOOAQCZYZHGUAZ-KATARQTJSA-N 0.000 description 3
- IJVNLNRVDUTWDD-MEYUZBJRSA-N Thr-Leu-Tyr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O IJVNLNRVDUTWDD-MEYUZBJRSA-N 0.000 description 3
- NWECYMJLJGCBOD-UNQGMJICSA-N Thr-Phe-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O NWECYMJLJGCBOD-UNQGMJICSA-N 0.000 description 3
- KERCOYANYUPLHJ-XGEHTFHBSA-N Thr-Pro-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O KERCOYANYUPLHJ-XGEHTFHBSA-N 0.000 description 3
- IEZVHOULSUULHD-XGEHTFHBSA-N Thr-Ser-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O IEZVHOULSUULHD-XGEHTFHBSA-N 0.000 description 3
- COYHRQWNJDJCNA-NUJDXYNKSA-N Thr-Thr-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O COYHRQWNJDJCNA-NUJDXYNKSA-N 0.000 description 3
- NJGMALCNYAMYCB-JRQIVUDYSA-N Thr-Tyr-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(O)=O NJGMALCNYAMYCB-JRQIVUDYSA-N 0.000 description 3
- QGVBFDIREUUSHX-IFFSRLJSSA-N Thr-Val-Gln Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O QGVBFDIREUUSHX-IFFSRLJSSA-N 0.000 description 3
- XKGZEDNYGPNJAR-XIRDDKMYSA-N Trp-Asn-His Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC3=CN=CN3)C(=O)O)N XKGZEDNYGPNJAR-XIRDDKMYSA-N 0.000 description 3
- BYSKNUASOAGJSS-NQCBNZPSSA-N Trp-Ile-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N BYSKNUASOAGJSS-NQCBNZPSSA-N 0.000 description 3
- PWPJLBWYRTVYQS-PMVMPFDFSA-N Trp-Phe-Leu Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O PWPJLBWYRTVYQS-PMVMPFDFSA-N 0.000 description 3
- GFHYISDTIWZUSU-QWRGUYRKSA-N Tyr-Asn-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O GFHYISDTIWZUSU-QWRGUYRKSA-N 0.000 description 3
- YGKVNUAKYPGORG-AVGNSLFASA-N Tyr-Asp-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O YGKVNUAKYPGORG-AVGNSLFASA-N 0.000 description 3
- KIJLSRYAUGGZIN-CFMVVWHZSA-N Tyr-Ile-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(O)=O KIJLSRYAUGGZIN-CFMVVWHZSA-N 0.000 description 3
- NYTKXWLZSNRILS-IFFSRLJSSA-N Val-Gln-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)N)O NYTKXWLZSNRILS-IFFSRLJSSA-N 0.000 description 3
- SSYBNWFXCFNRFN-GUBZILKMSA-N Val-Pro-Ser Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O SSYBNWFXCFNRFN-GUBZILKMSA-N 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- 108010077245 asparaginyl-proline Proteins 0.000 description 3
- 108010068265 aspartyltyrosine Proteins 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 108010044374 isoleucyl-tyrosine Proteins 0.000 description 3
- 108010051673 leucyl-glycyl-phenylalanine Proteins 0.000 description 3
- 108010045397 lysyl-tyrosyl-lysine Proteins 0.000 description 3
- 108010024607 phenylalanylalanine Proteins 0.000 description 3
- 108010083476 phenylalanyltryptophan Proteins 0.000 description 3
- 230000000607 poisoning effect Effects 0.000 description 3
- 108010079317 prolyl-tyrosine Proteins 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 108010048397 seryl-lysyl-leucine Proteins 0.000 description 3
- 108010026333 seryl-proline Proteins 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 108010061238 threonyl-glycine Proteins 0.000 description 3
- 108010073969 valyllysine Proteins 0.000 description 3
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 description 2
- 244000221633 Brassica rapa subsp chinensis Species 0.000 description 2
- YNNXQZDEOCYJJL-CIUDSAMLSA-N Gln-Arg-Asp Chemical compound C(C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)N)N)CN=C(N)N YNNXQZDEOCYJJL-CIUDSAMLSA-N 0.000 description 2
- 241001272567 Hominoidea Species 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- 241000258916 Leptinotarsa decemlineata Species 0.000 description 2
- XNQMZHLAYFWSGJ-HTUGSXCWSA-N Phe-Thr-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O XNQMZHLAYFWSGJ-HTUGSXCWSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 108010006785 Taq Polymerase Proteins 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 229940104302 cytosine Drugs 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000010195 expression analysis Methods 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 231100000225 lethality Toxicity 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 238000012257 pre-denaturation Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000012474 protein marker Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 102220162436 rs886047270 Human genes 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 229940113082 thymine Drugs 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 101100497219 Bacillus thuringiensis subsp. kurstaki cry1Ac gene Proteins 0.000 description 1
- 241000197194 Bulla Species 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 241000489975 Diabrotica Species 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102100037114 Elongin-C Human genes 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- UTOQQOMEJDPDMX-ACZMJKKPSA-N Gln-Ser-Asp Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O UTOQQOMEJDPDMX-ACZMJKKPSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 101001011859 Homo sapiens Elongin-A Proteins 0.000 description 1
- 101001011846 Homo sapiens Elongin-B Proteins 0.000 description 1
- 101000881731 Homo sapiens Elongin-C Proteins 0.000 description 1
- 101000836005 Homo sapiens S-phase kinase-associated protein 1 Proteins 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241000282553 Macaca Species 0.000 description 1
- 101710132659 Protein M6 Proteins 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 108010007131 Pulmonary Surfactant-Associated Protein B Proteins 0.000 description 1
- 102100032617 Pulmonary surfactant-associated protein B Human genes 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 241000563489 Sesamia inferens Species 0.000 description 1
- UVHFONIHVHLDDQ-IFFSRLJSSA-N Val-Thr-Glu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N)O UVHFONIHVHLDDQ-IFFSRLJSSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000037429 base substitution Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000000443 biocontrol Effects 0.000 description 1
- 238000003766 bioinformatics method Methods 0.000 description 1
- 201000000053 blastoma Diseases 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 102220367413 c.224A>G Human genes 0.000 description 1
- 239000004294 calcium hydrogen sulphite Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 201000008184 embryoma Diseases 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000012215 gene cloning Methods 0.000 description 1
- 238000012268 genome sequencing Methods 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000002708 random mutagenesis Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 102200080790 rs1057520333 Human genes 0.000 description 1
- 102220127702 rs375743726 Human genes 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 101150090432 sip1 gene Proteins 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000012916 structural analysis Methods 0.000 description 1
- 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
- C07K14/325—Bacillus thuringiensis crystal peptides, i.e. delta-endotoxins
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/40—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides
- A01N47/42—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides containing —N=CX2 groups, e.g. isothiourea
- A01N47/44—Guanidine; Derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Pest Control & Pesticides (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Crystallography & Structural Chemistry (AREA)
- Agronomy & Crop Science (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Peptides Or Proteins (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention relates to a Bacillus thuringiensis Sip1Aa protein random recombinant mutant protein, belonging to the technical field of biology. The invention obtains the Sip1Aa high-efficiency soluble insecticidal protein mutant M6 and M8 proteins, respectively changes an amino acid, improves the insecticidal activity of the obtained mutant protein M8 by 4.02 times and the insecticidal activity of M6 by 2.19 times, effectively overcomes the problem of searching a gene with high toxicity of the bacillus thuringiensis expression protein to the bullion, and delays the generation of drug resistance of pests to engineering bacteria and transgenic plants.
Description
Technical Field
The invention belongs to the technical field of biological control, and particularly relates to random recombinant mutant protein of Bt insecticidal gene with high toxicity to coleoptera agricultural pests.
Background
Bacillus thuringiensis (Bt) is a gram-positive bacterium, widely exists in nature, and generally has a short rod shape, and is single-grown or short-chain. In 1911, the German biologist Bellen (Berlinier) isolated the same bacterium from diseased larvae of Mediterranean pink borer, Scotch, Germany and named Bacillus thuringiensis. The bacillus thuringiensis has been studied for over 100 years, and reports on the bacillus thuringiensis relate to aspects of biomolecular science, cytology, classification nomenclature, effective components of Bt and insecticidal mechanism thereof, and the like, and the research reports are many tens of thousands.
At present, fewer reports on Bt Sip proteins are made at home and abroad. In the course of Donovan et al investigating the insecticidal activity of Bt strains against coleopteran insects, the culture supernatants of some strains were found to be Lethal (LC)50) The gene has insecticidal activity on Colorado Potato Beetle (CPB) larvae at 0.12 (0.09-0.15) mu.g/mL, comprises 1104bp, encodes 367 amino acids, is named as Sip1A, and has 46% of similarity with Mtx3 mosquito killing protein (Donovan W P, Engleman J T, Donovan J C, et al]Appl Microbiol Biotechnol,2006,72(4): 713-719). In 2012, the laboratory cloned and identified sip gene comprising 1038bp and encoding 345 amino acid sequences from Bt strain QZL26, but its insecticidal activity has not been reported (Liu Yangjie, Lihao, Liu Rong Mei, etc.. Bt novel gene sip cloning, expression and bioinformatics analysis [ J]Biotechnological notification 2012(12) 101-. In 2013, Murawska et al applied genome sequencing technology and found that the strain IS5056 contained the sip gene, but they were not studied in depth. In 2015, 1188bp Sip protein which encodes 395 amino acids and is cloned and expressed from Bt strain DQ89 by Zhang jin wave shows that the protein has higher poisoning effect on bulla and LC thereof50The value was 1.542. mu.g/mL (Zhang jin Bo, Liaotao, Liurongmei, etc.. Bt Strain DQ89 sip gene cloning, expression and insecticidal activity analysis [ J]The Chinese journal of biological control 2015,31(4): 598-. In addition, sandmonanthus chevalis clones sip1Aa gene from Bt strain QZL38, constructs its truncated mutant, removes the first 90bp signal peptide, and can produce 37.6kDa soluble eggWhite and tested for LC against bulleyana50The value was 1.051. mu.g/mL (Sha J, Zhang J, Chi B, et al. Sip1Abgene from a native Bacillus thuringiensis strain QZL38 and its induced activity acquisition of collagen bowring Baly [ J].Biocontrol Science&Technology,2018,28(5):459-467.)。
Theoretically, PCR amplification is an exponential growth process, but in practice, the amplification curve of PCR is not a standard "J" shaped exponential curve, but rather a curve that approximates a "S" shape. This occurs because the number of amplification cycles increases with PCR. The amplification scale is exponentially and rapidly increased, and the elements of various PCR reactions such as Taq enzyme, dNTPs, primers, even DNA templates and the like are gradually short of demand, so that the PCR efficiency is lower and lower, and the increase rate of products is also gradually slowed down. When all the raw materials required for PCR are consumed, the PCR is in a plateau phase, and the amount of PCR products is saturated. Due to the complex interaction among various factors, the opportunity and height of different PCR reaction systems entering the platform phase are greatly different.
And obtaining an amplification curve of the plasmid through fluorescent quantitative PCR, detecting the amplification process of the whole PCR, observing a base line phase, a logarithmic phase and a platform phase of PCR reaction, determining the cycle number of PCR entering exponential amplification under the condition of different template amounts, and calculating to obtain the exponential amplification cycle number required for reaching the expected mutation rate. Selecting a plasmid with a proper concentration capable of generating as much product quantity as possible as a template of error-prone PCR, carrying out PCR amplification by using Taq DNA polymerase, carrying out double enzyme digestion reaction with a vector plasmid after PCR product gel is recovered and purified, carrying out T4 ligase connection, then transforming to an escherichia coli LM109 competent cell, screening positive clone, and storing a transformant, thus obtaining the sip1Aa random recombinant library.
In the application, the Sip1Aa mutant protein with high activity is expected to be obtained by a random recombination method, and for the research on key amino acid residues of bacillus thuringiensis playing a poisoning effect on pests, the higher the mutation rate is, the better the mutation rate is, so that the selection of the proper mutation rate is important. In addition, the relationship between the structure and function of insecticidal proteins is studiedIt is generally advisable to study mutations of individual amino acid residues, i.e.about 1.5 base mutations per segment of the gene of interest. If only proteins with significant changes in properties are desired, it is possible to increase the amount of Mg in the PCR system2+The concentration can increase the mutation rate and expand the capacity of the mutation library. Even so, when the number of mutated bases in each segment of the target gene exceeds 6, the protein often loses its original function.
In addition, in previous studies on Cry proteins, a series of mutants were constructed by random mutagenesis, in which the mutants with increased insecticidal activity were all at low mutation frequencies, and when the mutation frequency was too high, most of the mutations were harmful and beneficial mutations could hardly be screened (Vartanian JP, Henry M, Wain-Hobson S. hypermutagenic PCR incorporation of all mutations and a sizeable breeding of transitions. nucleic Acids Res,1996,24(14): 2627) 2631.). Meanwhile, if the mutation frequency is too low, the wild-type protein will occupy the advantages of the mutation library, and the ideal mutants cannot be screened. Therefore, this study selects a low mutation frequency that would expect 1.5 base mutations per segment of the gene of interest, and constructs a random recombinant library of sip1 Aa.
Disclosure of Invention
In order to delay insect resistance and obtain mutant proteins with higher insecticidal activity, the research utilizes an error-prone PCR technology to construct a random recombination library of the Sip1Aa protein, randomly selects 100 positive transformants for sequence determination, and generates 25 mutants in total, which are respectively named as M1-M25. A total of 29 base mutations occurred, with an average of 1.2 base mutations per mutant. Compared with the Sip1Aa protein, the insecticidal activity of the mutant M1(A31, Y118 and D227), M5(K168) and M21(I307) is obviously reduced, the activity is reduced by 4-6 times, meanwhile, the mutant M8(R174S) with improved insecticidal activity on simian beetle is obtained, the activity is improved by 4.02 times, and the activity of the mutant M6(F346V) is improved by 2.19 times, and the research result provides reference for molecular modification of the Sip1Aa protein and research on key sites of the insecticidal activity.
Mutant M8(R174S), the amino acid sequence of which is as shown in SEQ ID No. 3.
A gene encoding the mutant M8 (R174S).
Mutant M6(F346V), the amino acid sequence of which is shown in SEQ ID No. 5.
A gene encoding the mutant M6(F346V) described above.
The gene sequence is shown in SEQ ID No.4 and SEQ ID No. 6.
The mutant SEQ ID No.3 and SEQ ID No.5 show application in killing great ape beetle pests.
The mutant SEQ ID No.3 and SEQ ID No.5 are prepared into an insecticide to kill the great ape beetles.
The invention constructs the random recombination library of the Sip1Aa protein by using the error-prone PCR technology, randomly selects 100 positive transformants for sequence determination, generates 25 mutants in total and is respectively named as M1-M25. A total of 29 base mutations occurred, with an average of 1.2 base mutations per mutant. Compared with wild type Sip1Aa protein, the insecticidal activity of the mutant M1(A31, Y118 and D227), M5(K168) and M21(I307) is obviously reduced, the LC50 value is increased by 4-6 times, and meanwhile, the mutant M8(R174S) with improved insecticidal activity to the simian beetle is obtained, and the LC50 value is reduced by 4 times; and the activity of the M6(F346V) mutant was increased 2.19-fold. The research result provides reference for molecular modification of the Sip1Aa protein and research of key sites of insecticidal activity.
Drawings
FIG. 1 fluorescent quantitative PCR amplification/cycling plot,
FIG. 2 shows the result of PCR amplification,
m: DL2000 DNA Marker, 1-2: the concentration of the pAc19sip1Aa plasmid template is 3.5 ng/. mu.L, 35 and 28 cycles of PCR amplification are carried out respectively; 3-4: plasmid template concentration of pAc19sip1Aa is 35 ng/. mu.L, PCR is respectively amplified for 35 and 13 cycles,
FIG. 3 shows the error-prone PCR product and the enzyme digestion of the vector,
m: DL5000 and DL2000, 1: xho I and EcoR I enzyme digestion plasmid pAc19sip1Aa, then recycling 3kb carrier; 2: after the Xho I and EcoR I enzyme digestion error-prone PCR glue recovery product, a 1kb target band is recovered,
figure 4 shows the distribution of the abrupt points,
FIG. 5 random mutation library protein expression analysis,
M:Premixed Protein Marker(Low),CK-:pUC19,P:pAc19Sip1Aa,1:M 1,2:M 2,3:M 5,4:M 6,5:M 7,6:M 8,7:M 10,8:M 11,9:M 13,10:M 17,11:M 18,12:M 19,13:M 21and 14:M 25,
FIG. 6 analysis of mutation site structure.
Detailed Description
The present invention will be described in further detail with reference to examples.
1. Materials and reagents
1.1 strains and plasmids
The strains and plasmids used in the experiments are detailed in Table 1 and can be distributed to the public.
TABLE 1 strains and plasmids
1.2 primers
Random mutation primer
Designing random mutation primers according to the sequence of the sip1Aa gene, introducing Xho I enzyme cutting sites at the 5 'end of an upstream primer, and introducing EcoR I enzyme cutting sites at the 5' end of a downstream primer. The primer sequences are shown in Table 2.
TABLE 2 primer names and sequences
1.3 Medium and antibiotics
Liquid LB: tryptone 1%, NaCl 1%, yeast extract 0.5%; ampicillin (Ampicillin) 100mg of Ampicillin (Ampicillin) was dissolved in 1ml of sterile water and diluted 1000-fold for use in 0.22 μm filter sterilization.
1.5 enzymes and Biochemical reagents
Protein Marker was purchased from TaKaRa corporation; 2 × Taq Mix DNA polymerase was purchased from CWBIO; the DNA gel recovery kit was purchased from Axygen; other reagents are domestic analytical pure reagents.
1.6 test insects
The standardized great ape beetle test insect used in the experiment is a gift from the plant protection research of the Chinese academy of agricultural sciences.
2 method of experiment
2.1 plasmid concentration determination
mu.L of the plasmid was collected and the concentration was determined using a NanoDrop apparatus. Plasmid concentration gradients were diluted to 35 ng/. mu.L and 3.5 ng/. mu.L.
2.2 fluorescent quantitative PCR reaction
The plasmid pAc19sip1Aa transformed with E.coli JM109 was used as a template, sip1Aa-Xho I and sip1Aa-EcoR I were used as a primer pair, and qpCR amplification of a sip1Aa gene fragment was performed, and the reaction system was as follows:
reaction procedure: pre-denaturation at 95 ℃ for 30s, denaturation at 95 ℃ for 10s, annealing at 60 ℃ for 30s, 40 cycles.
2.3 error-prone PCR reactions
A3.5 ng/. mu.L pAc19sip1Aa plasmid is used as a template, sip1Aa-Xho I and sip1Aa-EcoR I are used as primer pairs, and a sip1Aa gene fragment is amplified, wherein the reaction system is as follows:
PCR reaction procedure: pre-denaturation at 95 ℃ for 3min, denaturation at 95 ℃ for 30s, annealing at 59.8 ℃ for 30s, and extension at 72 ℃ for 1 min. 28 cycles of amplification and final extension at 72 ℃ for 10 min.
After the reaction is finished, the target fragment is recovered by glue.
2.4 enzyme digestion
Xho I and EcoRI are used for carrying out double enzyme digestion on pAc19sip1Aa plasmid and error-prone PCR gel recovery products simultaneously, and the reaction system is as follows:
reaction conditions are as follows: the reaction was carried out at 37 ℃ for 30 min.
After the reaction is finished, the enzyme digestion product is recovered by agarose gel.
2.5 ligation reaction
Connecting the double-restriction enzyme digestion vector fragment pAc19 after gel recovery with the error-prone PCR gel recovery product through T4 ligase, wherein the system is as follows:
reaction conditions are as follows: 16 ℃ overnight.
After the reaction, the Escherichia coli JM109 was transformed to be competent, and a random recombinant library was established.
2.6 sequencing and analysis
Screening positive clones in the random recombinant library, and randomly picking 100 positive clones for sequence determination.
2.7 random recombination library protein expression and extraction
(1) Selecting a recombinant single colony to be cultured in 5mL of liquid LB culture medium containing ampicillin at 37 ℃ and 220rpm/min for 12 h;
(2) inoculating into 100mL 2 XLB liquid culture medium according to 1% inoculum size, culturing at 37 deg.C and 220rpm/min for 16 h;
(3) centrifuging at 4 deg.C and 8000rpm/min for 10min, and collecting thallus;
(4) the precipitate was suspended in 5mL of 1 XTE solution;
(5) performing ultrasonic disruption in ice-water bath (80%, 3s, 3s, 10 min);
(6) centrifuging at 4 deg.C and 12000rpm/min for 10min, and collecting supernatant; SDS-PAGE detects protein expression.
(7) Suspending the precipitate with 2% Triton-100, centrifuging at 4 deg.C and 12000rpm for 10min, discarding the supernatant, and repeating for 3 times;
(8) suspending with sterile water, precipitating, centrifuging at 4 deg.C and 12000rpm/min for 10min, and removing supernatant;
(9) the pellet was suspended in 5mL PBS and stored until use.
2.8 SDS-PAGE electrophoresis
The polyacrylamide gel was formulated as shown in Table 3.
TABLE 3 formulation of SDS Polyacrylamide gels
Protein sample treatment: mixing 100 mu L of protein sample with 40 mu L of 5 Xloading buffer solution, then carrying out boiling water bath for 10min, and centrifuging at 12000rpm/min for 10 min;
loading and electrophoresis: and (3) taking 10 mu L of supernatant for sample loading, performing 80V pre-electrophoresis for 20min, and changing the condition of 120V electrophoresis until the protein sample is concentrated to a straight line.
Dyeing: after electrophoresis, the gel was removed, placed in a glass dish to which 100mL of SI had been added, heated with a microwave oven over a high fire for 30s, taken out and placed on a shaker, and decolorized at 70rpm/min for 5 min. The SI was decanted off and the gel was transferred to a glass dish to which 100mL SII and 2mL SIII had been added, heated on a microwave oven with a high fire for 30S, removed and placed on a shaker and stained at 70rpm/min for about 20min until a clear band appeared. The gel was removed and transferred to a glass dish containing distilled water and decolorized overnight at 70 rpm/min.
Imaging: the gel is stored by photographing through a gel imaging system.
2.9 insecticidal Activity assay
pAc19-Sip1Aa protein and random recombinant protein were diluted to different concentrations, and the virulence analysis was performed on the simian diabrotica using fresh pakchoi by leaf dip bioassay with the protein expressed from pUC19 in E.coli as negative control. The specific method comprises the following steps:
(1) selecting fresh and uniform-sized pakchoi leaves, cleaning with distilled water, and placing on filter paper for airing;
(2) putting a protein sample to be detected into a sterile culture dish, adding 0.1% household detergent into the sample, soaking the leaves in the protein sample for about 30s, and turning over the leaves once;
(3) placing the leaves on a preservative film for airing;
(4) putting the dried leaves into culture dishes paved with filter paper wetted by sterilized water respectively;
(5) gently inoculating the larva of the great ape concha into the brush pen, inoculating 16 heads of the larva to each leaf, and repeating the treatment for three times;
(6) placing in a biochemical incubator at 27 deg.C, spraying appropriate amount of sterilized water in the incubator in the morning and evening to maintain the humidity of the incubator air, and controlling the light cycle to 14/10 (light/dark);
counting the number of dead insects and the number of live insects in 48h, and calculating the mortality, correcting the mortality and LC by adopting SPSS software50(95% confidence interval).
3 results of the test
3.1 determination of initial template concentration for PCR amplification
The concentration of pAc19sip1Aa plasmid was 268.3 ng/. mu.L as measured by a microspectrophotometer, Narodrop. The plasmid was diluted to 35 ng/. mu.L and 3.5 ng/. mu.L, and 1. mu.L of plasmid was taken as a template, and fluorescence quantitative PCR was performed using sip1Aa-Xho I and sip1Aa-EcoR I as primer pairs, while negative control was performed using water as a template, and each condition was repeated 3 times. The qPCR amplification results are shown in figure 1.
Since different PCR exponential amplification cycles lead to different mutation frequencies, the amplification of the pAc19sip1Aa plasmid was investigated by quantitative fluorescence PCR. According to the results of FIG. 1, when the concentration of pAc19sip1Aa plasmid template was 35 ng/. mu.L, PCR was in the exponential amplification phase at 10-22 cycles; when the concentration of pAc19sip1Aa plasmid template was 3.5 ng/. mu.L, PCR was in the exponential amplification phase at 25-35 cycles.
According to the calculation result, when the initial concentration of the pAc19sip1Aa plasmid template is 35 ng/. mu.L, 13 PCR cycles are needed to obtain the mutation rate of 1.5 bases; when the initial concentration of pAc19sip1Aa plasmid template was 3.5 ng/. mu.L, 28 PCR cycles were required. The results of PCR amplification under these conditions are shown in FIG. 2.
As can be seen from FIG. 2, the amount of PCR product increased with the increase of the number of PCR cycles with the same amount of template before the PCR amplification reached saturation. After the PCR products are subjected to gel recovery, concentration measurement shows that the initial concentration of the pAc19sip1Aa plasmid template is 35 ng/. mu.L, and the concentration of the products obtained by 13 PCR cycles of amplification is obviously lower than that of the products obtained by 28 PCR cycles of amplification, wherein the initial concentration of the pAc19sip1Aa plasmid template is 3.5 ng/. mu.L. For the convenience of subsequent gel recovery, enzyme digestion and other operations, pAc19sip1Aa plasmid template with initial concentration of 3.5 ng/. mu.L and 28 PCR cycles were selected as conditions for establishing random recombination library.
3.2 Generation of random recombinant libraries
The pAc19sip1Aa plasmid at an initial concentration of 3.5 ng/. mu.L was used as a template for error-prone PCR reactions, and after 28 cycles of PCR amplification, the product was recovered in gel. Then carrying out double enzyme digestion on the gel recovery product by using restriction enzymes Xho I and EcoR I, and recovering a target band with the size of 1 kb; at the same time, the pAc19sip1Aa plasmid was double digested with restriction enzymes Xho I and EcoR I, and the vector fragment of 3kb in size was recovered from the gel, as shown in FIG. 3. And connecting the gel recovery products of the two products according to a reaction system of T4 ligase, carrying out overnight reaction at 16 ℃, transforming E.coli JM109 competent cells, screening positive clones, and storing 1000 positive transformants in total to establish the sip1Aa random recombinant library.
3.3 random recombination library sequence analysis
In order to verify the base change of the random mutation target fragment, 100 positive transformants are randomly selected from the random mutation library for sequence determination, and the sequencing result is analyzed. Among them, 25 mutants were subjected to base change and named M1-M25, respectively. The statistics of the nucleotide and amino acid changes in the mutants are shown in Table 4.
TABLE 4 mutant base and amino acid sequences in random recombination libraries
Of the 100 transformants sequenced, 11 mutants had nucleotide changes but did not cause amino acid changes. The total number of mutants with nucleotide changes and amino acid changes is 14, accounting for 14%. Mutants with missense mutations were M1, M2, M5, M6, M7, M8, M10, M11, M13, M17, M18, M19, M21 and M25, respectively. Among the 25 mutants obtained, no mutation occurred and no mutation of base insertion and deletion was observed, even though a stop codon was generated after the mutation.
Sequencing analysis of 100 positive transformants showed that 25 mutants out of 100 transformants had base mutations, resulting in 29 nucleotide site mutations (Table 4), and that each mutant had 1.2 base mutations on average, which was substantially identical to the expected 1.5 base mutations per mutant. Of the 29 mutated nucleotide sites, most of the base substitutions occurred AT → GC, accounting for 82.8% of the total mutated sites, with less mutations of guanine and cytosine, only 3.4%, consistent with the previously reported propensity of Taq DNA polymerase to have AT → GC mismatches when performing PCR reactions.
3.4 distribution of abrupt change sites
Statistical analysis of 29 base mutation sites in the random mutation library using Origin 8.0 is shown in FIG. 4. Between 91 bp and 1005bp of the nucleotide sequence of sip1Aa, the base sites with mutation are distributed more uniformly, and no mutation hot spots are found. Except for the 1036 th base, 1 mutation is carried out on each base site. In the mutant M6, the 1036 th thymine is mutated into guanine, so that 346 th phenylalanine is replaced by valine; in the mutant M13, the 1036 th thymine was mutated to cytosine, resulting in the 346 th phenylalanine being mutated to leucine.
3.5 random mutant library protein expression
The proteins expressed by the recombinant strains in the random recombinant library in Escherichia coli JM109 were extracted, and SDS-PAGE analysis of the expression of the mutant proteins with missense mutation was performed, as shown in FIG. 5. Sip1Aa protein expressed under the guidance of cry1Ac promoter is used as a positive control, and pUC19 expressed in escherichia coli is used as a negative control. The results showed that all mutants in the random mutant library were successfully expressed in E.coli, and the expressed product contained 37.6kDa protein of interest, which was identical in size to Sip1Aa protein (FIG. 5).
3.6 measurement of biological Activity
Preliminary activity tests were first carried out on 14 mutants and the results showed that the lethality of the muteins M6(F346V) and M8(R174S) to bullosa was higher than that of the pAcSip1Aa protein and that the insecticidal activity of the muteins M1(A31G, Y118C, D227E), M2(N305I, T324A), M5(K168R) and M21(I307T) to bullosa was lower than that of pAcSip1 Aa. The muteins M7(F89L), M10(K168N), M11(I45V), M13(F364L), M17(D141G), M18(N317D), M19(K193K, E235G), M25(N75S) and pAcSip1Aa have no significant difference in the lethality to bullous apes.
TABLE 5 insecticidal results of Sip1Aa random muteins against Bullenia apetala
Mutants M1, M2, M5, M6, M8 and M21 were purified and used for counterscreening of the apes beetles, with PBS buffer as negative control. The protein concentration of the rescreened solution is set to be six concentration gradients of 0.1 mu g/mL, 1 mu g/mL, 5 mu g/mL, 10 mu g/mL, 20 mu g/mL and 50 mu g/mL, three times of repetition is set for each concentration, 16 head worms are inoculated in each repetition, after the solution is cultured in a climatic chamber at the temperature of 27 ℃ for 48 hours, the death condition of the insects is counted, and LC is calculated50The value is obtained. The results of the biological activity assay rescreening are shown in Table 5.
TABLE 5 quantitative determination of the biological Activity of the Sip1Aa random mutein against the great Simian Blastoma
As can be seen from Table 6, the activity of the mutant M8 is greatly improved, the insecticidal activity against the great ape beetle is obviously better than that of pAc19Sip1Aa, the activity is improved by 4.02 times, and the insecticidal activity against the great ape beetle is improved by 2.19 times by the mutant M6. The insecticidal activity of the mutants M2 on the great ape beetle is slightly lower than that of pAc19Sip1Aa, M1, M5 and M21 on the great ape beetle, and the insecticidal activity is obviously lower than that of pAc19Sip1Aa protein, and is reduced by 4 times, 5 times and 6 times.
3.7 analysis of mutant site Structure
The structural analysis of the M1(A31, Y118, D227), M5(K168), M8(R174) and M21(I307) sites of mutants in a random recombination library of Sip1Aa protein was performed using PDB Viewer software.
Y118 and D260 are capable of forming two intramolecular hydrogen bonds, each having a bond length ofAnd(a in FIG. 6). When threonine 118 is replaced by cysteine, C118 and D260 can only form a hydrogen bond with the length of(b in FIG. 6). D227 and Y176 form two hydrogen bonds with the bond lengths ofAnd(c in FIG. 6). When the 227 th aspartic acid is mutated into glutamic acid, E227 can form two hydrogen bonds with Y176, but the bond length is changed, namelyAndas shown at d in fig. 6. The mutation of A31G had no significant effect on the structure of the Sip1Aa protein. These mutations result in a reduction in the stability of mutant M1 compared to the wild-type Sip1Aa protein, resulting in a reduction in insecticidal activity against the macaca apelta.
The two bonds of the K168 and V236 forms in mutant M5 are of lengthAndhydrogen bonds (e in fig. 6). When lysine 168 was replaced by arginine, the hydrogen bond disappeared (f in FIG. 6). The hydrogen bond formed by I307 and T306 in mutant M21 is as long as(i in FIG. 6). After I307 was substituted with threonine, the hydrogen bond disappeared. Hydrogen bonding can maintain steric stabilization. The mutants M5 and M21 lose stable intramolecular hydrogen bonds, possibly resulting in the change of the spatial structure of the protein and reducing the insecticidal activity of the protein on the great ape beetle.
The arginine at position 174 in mutant M8 is located on the β 11 fold, as indicated by g in FIG. 6. When the basic arginine at position 174 was replaced with a neutral serine (h in FIG. 6), the mutant protein was increased 4-fold compared to the wild-type Sip1Aa protein. It is possible that at this position, neutral amino acids are more favorable for the Sip1Aa protein to exert a poisoning effect in the great ape beetle.
4 conclusion
The invention adopts the random recombination technology to transform the Sip1Aa protein, the insecticidal activity of the mutants M8 and M6 is obviously improved, the activity of the mutant M8 is improved by 4.02 times, and the insecticidal activity of the mutant M6 on the great ape beetle is improved by 2.19 times. In addition, because the promoter of the vector is changed, the expression quantity of the protein M8 and M6 of the Sip1Aa mutant is improved, the solubility is high, and the stability is good.
Sequence listing
<110> northeast university of agriculture
<120> Sip1Aa protein random recombinant mutant protein
<141> 2020-12-02
<160> 6
<170> SIPOSequenceListing 1.0
<210> 1
<211> 364
<212> PRT
<213> Bacillus thuringiensis (Bacillus thuringiensis)
<400> 1
Met Lys Tyr Lys Phe Ser Lys Val Val Lys Cys Thr Leu Pro Ala Leu
1 5 10 15
Met Ile Thr Thr Phe Val Thr Pro Ser Met Ala Val Phe Ala Ala Glu
20 25 30
Thr Lys Ser Pro Asn Leu Asn Ala Ser Gln Gln Ala Ile Thr Pro Tyr
35 40 45
Ala Glu Ser Tyr Ile Asp Thr Val Gln Asp Arg Met Lys Gln Arg Asp
50 55 60
Arg Glu Ser Lys Leu Thr Gly Lys Pro Ile Asn Met Gln Glu Gln Ile
65 70 75 80
Ile Asp Gly Trp Phe Leu Ala Arg Phe Trp Ile Phe Lys Asp Gln Asn
85 90 95
Asn Asn His Gln Thr Asn Arg Phe Ile Ser Trp Phe Lys Asp Asn Leu
100 105 110
Ala Ser Ser Lys Gly Tyr Asp Ser Ile Ala Glu Gln Met Gly Leu Lys
115 120 125
Ile Glu Ala Leu Asn Asp Met Asp Val Thr Asn Ile Asp Tyr Thr Ser
130 135 140
Lys Thr Gly Asp Thr Ile Tyr Asn Gly Ile Ser Glu Leu Thr Asn Tyr
145 150 155 160
Thr Gly Thr Thr Gln Lys Met Lys Thr Asp Ser Phe Gln Arg Asp Tyr
165 170 175
Thr Lys Ser Glu Ser Thr Ser Val Thr Asn Gly Leu Gln Leu Gly Phe
180 185 190
Lys Val Ala Ala Lys Gly Val Val Ala Leu Ala Gly Ala Asp Phe Glu
195 200 205
Thr Ser Val Thr Tyr Asn Leu Ser Ser Thr Thr Thr Glu Thr Asn Thr
210 215 220
Ile Ser Asp Lys Phe Thr Val Pro Ser Gln Glu Val Thr Leu Ser Pro
225 230 235 240
Gly His Lys Ala Val Val Lys His Asp Leu Arg Lys Met Val Tyr Phe
245 250 255
Gly Thr Gln Asp Leu Lys Gly Asp Leu Lys Val Ser Phe Asn Asp Lys
260 265 270
Glu Ile Val Gln Lys Phe Ile Tyr Pro Asn Tyr Arg Ser Ile Asp Leu
275 280 285
Ser Asp Ile Arg Lys Thr Met Ile Glu Ile Asp Lys Trp Asn His Val
290 295 300
Asn Thr Ile Asp Phe Tyr Gln Leu Val Gly Val Lys Asn His Ile Lys
305 310 315 320
Asn Gly Asp Thr Leu Tyr Ile Asp Thr Pro Ala Glu Phe Thr Phe Asn
325 330 335
Gly Ala Asn Pro Tyr Tyr Arg Ala Thr Phe Thr Glu Tyr Asp Glu Asn
340 345 350
Gly Asn Pro Val Gln Thr Lys Ile Leu Ser Gly Asn
355 360
<210> 2
<211> 1095
<212> DNA
<213> Bacillus thuringiensis (Bacillus thuringiensis)
<400> 2
atgaaataca agttttcaaa agtcgttaag tgtactttac cagctttaat gattactaca 60
ttcgttactc caagtatggc agtttttgcc gcagaaacca agtcgccaaa tctaaatgca 120
tctcaacaag caataactcc atatgctgaa tcttatattg atacggttca agatagaatg 180
aaacaaagag atagggaatc aaaactaact ggtaagccaa taaatatgca agaacaaata 240
atagatggat ggtttttagc tagattctgg atatttaaag atcaaaataa caatcatcaa 300
acaaatagat ttatatcctg gtttaaagat aatcttgcta gttcgaaggg gtatgacagt 360
atagcagaac aaatgggctt aaaaatagaa gcattaaatg atatggatgt aacaaatatt 420
gattatacat ctaaaacagg tgataccata tataatggaa tttctgaact aacaaattat 480
acaggaacaa cccaaaaaat gaaaaccgat agttttcaaa gagattatac aaaatctgaa 540
tccacttcag taacaaatgg gttacaatta ggatttaaag ttgctgctaa gggagtagtt 600
gcattagcag gtgcagattt tgaaacaagt gttacctata atttatcatc tactacaact 660
gaaacaaata caatatcgga taagtttact gttccatctc aagaagttac attatcccca 720
ggtcataaag cagtagtgaa acatgatttg agaaaaatgg tgtattttgg gactcaagat 780
ttaaagggtg atttaaaagt aagttttaat gataaagaga ttgtacaaaa atttatttat 840
ccaaattata gatcaattga tttatctgat attcgtaaaa caatgattga aattgataaa 900
tggaatcatg taaataccat tgacttttat caattagttg gagttaaaaa tcatataaaa 960
aatggtgata ctttatatat agataccccg gccgaattta catttaatgg agctaatcca 1020
tattatagag caacatttac agaatacgac gagaacggaa atcctgttca aacaaagatt 1080
ttaagtggaa attaa 1095
<210> 3
<211> 364
<212> PRT
<213> Artificial Sequence (Artificial Sequence)
<400> 3
Met Lys Tyr Lys Phe Ser Lys Val Val Lys Cys Thr Leu Pro Ala Leu
1 5 10 15
Met Ile Thr Thr Phe Val Thr Pro Ser Met Ala Val Phe Ala Ala Glu
20 25 30
Thr Lys Ser Pro Asn Leu Asn Ala Ser Gln Gln Ala Ile Thr Pro Tyr
35 40 45
Ala Glu Ser Tyr Ile Asp Thr Val Gln Asp Arg Met Lys Gln Arg Asp
50 55 60
Arg Glu Ser Lys Leu Thr Gly Lys Pro Ile Asn Met Gln Glu Gln Ile
65 70 75 80
Ile Asp Gly Trp Phe Leu Ala Arg Phe Trp Ile Phe Lys Asp Gln Asn
85 90 95
Asn Asn His Gln Thr Asn Arg Phe Ile Ser Trp Phe Lys Asp Asn Leu
100 105 110
Ala Ser Ser Lys Gly Tyr Asp Ser Ile Ala Glu Gln Met Gly Leu Lys
115 120 125
Ile Glu Ala Leu Asn Asp Met Asp Val Thr Asn Ile Asp Tyr Thr Ser
130 135 140
Lys Thr Gly Asp Thr Ile Tyr Asn Gly Ile Ser Glu Leu Thr Asn Tyr
145 150 155 160
Thr Gly Thr Thr Gln Lys Met Lys Thr Asp Ser Phe Gln Ser Asp Tyr
165 170 175
Thr Lys Ser Glu Ser Thr Ser Val Thr Asn Gly Leu Gln Leu Gly Phe
180 185 190
Lys Val Ala Ala Lys Gly Val Val Ala Leu Ala Gly Ala Asp Phe Glu
195 200 205
Thr Ser Val Thr Tyr Asn Leu Ser Ser Thr Thr Thr Glu Thr Asn Thr
210 215 220
Ile Ser Asp Lys Phe Thr Val Pro Ser Gln Glu Val Thr Leu Ser Pro
225 230 235 240
Gly His Lys Ala Val Val Lys His Asp Leu Arg Lys Met Val Tyr Phe
245 250 255
Gly Thr Gln Asp Leu Lys Gly Asp Leu Lys Val Ser Phe Asn Asp Lys
260 265 270
Glu Ile Val Gln Lys Phe Ile Tyr Pro Asn Tyr Arg Ser Ile Asp Leu
275 280 285
Ser Asp Ile Arg Lys Thr Met Ile Glu Ile Asp Lys Trp Asn His Val
290 295 300
Asn Thr Ile Asp Phe Tyr Gln Leu Val Gly Val Lys Asn His Ile Lys
305 310 315 320
Asn Gly Asp Thr Leu Tyr Ile Asp Thr Pro Ala Glu Phe Thr Phe Asn
325 330 335
Gly Ala Asn Pro Tyr Tyr Arg Ala Thr Phe Thr Glu Tyr Asp Glu Asn
340 345 350
Gly Asn Pro Val Gln Thr Lys Ile Leu Ser Gly Asn
355 360
<210> 4
<211> 1095
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 4
atgaaataca agttttcaaa agtcgttaag tgtactttac cagctttaat gattactaca 60
ttcgttactc caagtatggc agtttttgcc gcagaaacca agtcgccaaa tctaaatgca 120
tctcaacaag caataactcc atatgctgaa tcttatattg atacggttca agatagaatg 180
aaacaaagag atagggaatc aaaactaact ggtaagccaa taaatatgca agaacaaata 240
atagatggat ggtttttagc tagattctgg atatttaaag atcaaaataa caatcatcaa 300
acaaatagat ttatatcctg gtttaaagat aatcttgcta gttcgaaggg gtatgacagt 360
atagcagaac aaatgggctt aaaaatagaa gcattaaatg atatggatgt aacaaatatt 420
gattatacat ctaaaacagg tgataccata tataatggaa tttctgaact aacaaattat 480
acaggaacaa cccaaaaaat gaaaaccgat agttttcaaa gagtttatac aaaatctgaa 540
tccacttcag taacaaatgg gttacaatta ggatttaaag ttgctgctaa gggagtagtt 600
gcattagcag gtgcagattt tgaaacaagt gttacctata atttatcatc tactacaact 660
gaaacaaata caatatcgga taagtttact gttccatctc aagaagttac attatcccca 720
ggtcataaag cagtagtgaa acatgatttg agaaaaatgg tgtattttgg gactcaagat 780
ttaaagggtg atttaaaagt aagttttaat gataaagaga ttgtacaaaa atttatttat 840
ccaaattata gatcaattga tttatctgat attcgtaaaa caatgattga aattgataaa 900
tggaatcatg taaataccat tgacttttat caattagttg gagttaaaaa tcatataaaa 960
aatggtgata ctttatatat agataccccg gccgaattta catttaatgg agctaatcca 1020
tattatagag caacatttac agaatacgac gagaacggaa atcctgttca aacaaagatt 1080
ttaagtggaa attaa 1095
<210> 5
<211> 364
<212> PRT
<213> Artificial Sequence (Artificial Sequence)
<400> 5
Met Lys Tyr Lys Phe Ser Lys Val Val Lys Cys Thr Leu Pro Ala Leu
1 5 10 15
Met Ile Thr Thr Phe Val Thr Pro Ser Met Ala Val Phe Ala Ala Glu
20 25 30
Thr Lys Ser Pro Asn Leu Asn Ala Ser Gln Gln Ala Ile Thr Pro Tyr
35 40 45
Ala Glu Ser Tyr Ile Asp Thr Val Gln Asp Arg Met Lys Gln Arg Asp
50 55 60
Arg Glu Ser Lys Leu Thr Gly Lys Pro Ile Asn Met Gln Glu Gln Ile
65 70 75 80
Ile Asp Gly Trp Phe Leu Ala Arg Phe Trp Ile Phe Lys Asp Gln Asn
85 90 95
Asn Asn His Gln Thr Asn Arg Phe Ile Ser Trp Phe Lys Asp Asn Leu
100 105 110
Ala Ser Ser Lys Gly Tyr Asp Ser Ile Ala Glu Gln Met Gly Leu Lys
115 120 125
Ile Glu Ala Leu Asn Asp Met Asp Val Thr Asn Ile Asp Tyr Thr Ser
130 135 140
Lys Thr Gly Asp Thr Ile Tyr Asn Gly Ile Ser Glu Leu Thr Asn Tyr
145 150 155 160
Thr Gly Thr Thr Gln Lys Met Lys Thr Asp Ser Phe Gln Arg Asp Tyr
165 170 175
Thr Lys Ser Glu Ser Thr Ser Val Thr Asn Gly Leu Gln Leu Gly Phe
180 185 190
Lys Val Ala Ala Lys Gly Val Val Ala Leu Ala Gly Ala Asp Phe Glu
195 200 205
Thr Ser Val Thr Tyr Asn Leu Ser Ser Thr Thr Thr Glu Thr Asn Thr
210 215 220
Ile Ser Asp Lys Phe Thr Val Pro Ser Gln Glu Val Thr Leu Ser Pro
225 230 235 240
Gly His Lys Ala Val Val Lys His Asp Leu Arg Lys Met Val Tyr Phe
245 250 255
Gly Thr Gln Asp Leu Lys Gly Asp Leu Lys Val Ser Phe Asn Asp Lys
260 265 270
Glu Ile Val Gln Lys Phe Ile Tyr Pro Asn Tyr Arg Ser Ile Asp Leu
275 280 285
Ser Asp Ile Arg Lys Thr Met Ile Glu Ile Asp Lys Trp Asn His Val
290 295 300
Asn Thr Ile Asp Phe Tyr Gln Leu Val Gly Val Lys Asn His Ile Lys
305 310 315 320
Asn Gly Asp Thr Leu Tyr Ile Asp Thr Pro Ala Glu Phe Thr Phe Asn
325 330 335
Gly Ala Asn Pro Tyr Tyr Arg Ala Thr Val Thr Glu Tyr Asp Glu Asn
340 345 350
Gly Asn Pro Val Gln Thr Lys Ile Leu Ser Gly Asn
355 360
<210> 6
<211> 1095
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 6
atgaaataca agttttcaaa agtcgttaag tgtactttac cagctttaat gattactaca 60
ttcgttactc caagtatggc agtttttgcc gcagaaacca agtcgccaaa tctaaatgca 120
tctcaacaag caataactcc atatgctgaa tcttatattg atacggttca agatagaatg 180
aaacaaagag atagggaatc aaaactaact ggtaagccaa taaatatgca agaacaaata 240
atagatggat ggtttttagc tagattctgg atatttaaag atcaaaataa caatcatcaa 300
acaaatagat ttatatcctg gtttaaagat aatcttgcta gttcgaaggg gtatgacagt 360
atagcagaac aaatgggctt aaaaatagaa gcattaaatg atatggatgt aacaaatatt 420
gattatacat ctaaaacagg tgataccata tataatggaa tttctgaact aacaaattat 480
acaggaacaa cccaaaaaat gaaaaccgat agttttcaaa gagattatac aaaatctgaa 540
tccacttcag taacaaatgg gttacaatta ggatttaaag ttgctgctaa gggagtagtt 600
gcattagcag gtgcagattt tgaaacaagt gttacctata atttatcatc tactacaact 660
gaaacaaata caatatcgga taagtttact gttccatctc aagaagttac attatcccca 720
ggtcataaag cagtagtgaa acatgatttg agaaaaatgg tgtattttgg gactcaagat 780
ttaaagggtg atttaaaagt aagttttaat gataaagaga ttgtacaaaa atttatttat 840
ccaaattata gatcaattga tttatctgat attcgtaaaa caatgattga aattgataaa 900
tggaatcatg taaataccat tgacttttat caattagttg gagttaaaaa tcatataaaa 960
aatggtgata ctttatatat agataccccg gccgaattta catttaatgg agctaatcca 1020
tattatagag caacagttac agaatacgac gagaacggaa atcctgttca aacaaagatt 1080
ttaagtggaa attaa 1095
Claims (10)
1. The amino acid sequence of the mutant M8 is shown in SEQ ID No. 3.
2. A gene encoding the mutant M8 of claim 1.
3. The gene of claim 2, wherein the nucleotide sequence is shown in SEQ ID No. 4.
4. Use of the mutant M8 according to claim 1 for killing a pest simian beetle.
5. The use according to claim 4, wherein the mutant M8 of claim 1 is formulated as an insecticide against bulleyaconitum apetalum.
6. The amino acid sequence of the mutant M6 is shown in SEQ ID No. 5.
7. A gene encoding the mutant M6 of claim 6.
8. The gene of claim 7, wherein the nucleotide sequence is shown in SEQ ID No. 6.
9. Use of the mutant M6 according to claim 6 for killing a pest simian beetle.
10. The use according to claim 9, wherein the mutant M6 according to claim 6 is formulated as an insecticide against bulleyana.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011390510.6A CN112480220B (en) | 2020-12-02 | 2020-12-02 | Random recombinant mutant protein of Sip1Aa protein of bacillus thuringiensis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011390510.6A CN112480220B (en) | 2020-12-02 | 2020-12-02 | Random recombinant mutant protein of Sip1Aa protein of bacillus thuringiensis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112480220A true CN112480220A (en) | 2021-03-12 |
CN112480220B CN112480220B (en) | 2021-10-12 |
Family
ID=74939017
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011390510.6A Active CN112480220B (en) | 2020-12-02 | 2020-12-02 | Random recombinant mutant protein of Sip1Aa protein of bacillus thuringiensis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112480220B (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060191034A1 (en) * | 2003-07-07 | 2006-08-24 | Baum James A | Insecticidal proteins secreted from bacillus thuringiensis and uses therefor |
US20080040827A1 (en) * | 2003-12-16 | 2008-02-14 | Judith Donovan | Secreted Insecticidal Protein and Gene Compositions from Bacillus Thuringiensis and Uses Therefor |
CN101255432A (en) * | 2008-03-03 | 2008-09-03 | 创世纪转基因技术有限公司 | Artificial reconstruction synthetic pesticidal gene as well as encoding protein and use thereof |
US20100199383A1 (en) * | 2008-09-18 | 2010-08-05 | Pioneer Hi-Bred International, Inc. | Novel Bacillus Thuringiensis Gene with Coleopteran Activity |
CN102718872A (en) * | 2012-06-20 | 2012-10-10 | 中国农业科学院植物保护研究所 | Bacillus thuringiensis gene combination and engineering bacteria and preparation method thereof |
CN104388349A (en) * | 2014-11-21 | 2015-03-04 | 东北农业大学 | Insecticidal gene sip1A secreted by bacillus thuringiensis as well as expression protein and application thereof |
CN106632624A (en) * | 2016-09-21 | 2017-05-10 | 中国农业科学院植物保护研究所 | Insecticide protein and nucleic acid, preparation method and application thereof |
-
2020
- 2020-12-02 CN CN202011390510.6A patent/CN112480220B/en active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060191034A1 (en) * | 2003-07-07 | 2006-08-24 | Baum James A | Insecticidal proteins secreted from bacillus thuringiensis and uses therefor |
CN1849397A (en) * | 2003-07-07 | 2006-10-18 | 孟山都技术有限公司 | Insecticidal proteins secreted from bacillus thuringiensis and uses therefor |
US20080040827A1 (en) * | 2003-12-16 | 2008-02-14 | Judith Donovan | Secreted Insecticidal Protein and Gene Compositions from Bacillus Thuringiensis and Uses Therefor |
CN101255432A (en) * | 2008-03-03 | 2008-09-03 | 创世纪转基因技术有限公司 | Artificial reconstruction synthetic pesticidal gene as well as encoding protein and use thereof |
US20100199383A1 (en) * | 2008-09-18 | 2010-08-05 | Pioneer Hi-Bred International, Inc. | Novel Bacillus Thuringiensis Gene with Coleopteran Activity |
CN102718872A (en) * | 2012-06-20 | 2012-10-10 | 中国农业科学院植物保护研究所 | Bacillus thuringiensis gene combination and engineering bacteria and preparation method thereof |
CN104388349A (en) * | 2014-11-21 | 2015-03-04 | 东北农业大学 | Insecticidal gene sip1A secreted by bacillus thuringiensis as well as expression protein and application thereof |
CN106632624A (en) * | 2016-09-21 | 2017-05-10 | 中国农业科学院植物保护研究所 | Insecticide protein and nucleic acid, preparation method and application thereof |
Non-Patent Citations (9)
Title |
---|
JING WANG 等: ""In silico Structure-Based Investigation of Key Residues of Insecticidal Activity of Sip1Aa Protein"", 《FRONT MICROBIOL》 * |
JOAQUÍN GOMIS-CEBOLLA 等: ""A Genomic and Proteomic Approach to Identify and Quantify the Expressed Bacillus thuringiensis Proteins in the Supernatant and Parasporal Crystal"", 《TOXINS (BASEL)》 * |
PETIT,L. 等: ""ETX/MTX2 family pore-forming toxin [Bacillus thuringiensis]"", 《GENBANK》 * |
YUE-MING DING 等: ""Construction and analysis of Sip1Aa insecticidal protein random recombination library"", 《JOURNAL OF ASIA-PACIFIC ENTOMOLOGY》 * |
ZHANG,J.B. 等: ""secreted coleopteran active protein [Bacillus thuringiensis]"", 《GENBANK》 * |
刘艳杰 等: ""Bt新型基因sip的克隆、表达和生物信息学分析"", 《生物技术通报》 * |
张金波 等: ""Bt菌株DQ89的sip基因的克隆、表达及杀虫活性分析"", 《中国生物防治学报》 * |
王静: ""苏云金芽胞杆菌Sip1Aa蛋白杀虫活性关键位点的研究"", 《中国优秀硕士学位论文全文数据库(电子期刊) 农业科技辑》 * |
雷会霄: ""苏云金芽孢杆菌的分离鉴定及杀虫基因的克隆"", 《中国优秀硕士学位论文全文数据库(电子期刊) 农业科技辑》 * |
Also Published As
Publication number | Publication date |
---|---|
CN112480220B (en) | 2021-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2782300C (en) | Gene dro1 controlling deep-rooted characteristics of plant and utilization of same | |
GB2187462A (en) | Expression of genes in plants and plant cell cultures using promotors from root-nodule specific genes | |
AU2015297522B2 (en) | Plant body ideal for high-density planting and use thereof | |
CN110066322B (en) | Bt protein Cyt2-like and gene and application thereof | |
CN108250279B (en) | Application of heat shock protein Hsp17.6CII in regulation and control of saline-alkali tolerance of plants | |
CN112480220B (en) | Random recombinant mutant protein of Sip1Aa protein of bacillus thuringiensis | |
CN110938118A (en) | Plant immune activation protein PC2 secreted by phytophthora infestans and application thereof | |
CN110894221A (en) | Strawberry maturation associated transcription factor gene FaNAC2 and application thereof | |
CN111909252B (en) | Ginseng PgbHLH149 transcription factor and application thereof | |
CN111793118A (en) | CheY2 mutant protein and application thereof | |
CN109734789B (en) | Migratory locust FK506 binding protein 46 and coding gene and application thereof | |
CN107326035A (en) | A kind of adjusting and controlling rice grain type and the deubiquitination enzyme gene UBP5 of leaf color and its application | |
CN110894218A (en) | Plant immune activator protein SCR50 secreted by phytophthora infestans and application thereof | |
RU2020113297A (en) | DNA vaccine against SARS-CoV-2 virus based on gene therapy DNA vector GDTT1.8NAS12, method of its production, strains carrying gene therapy DNA vectors, method of their production, method of industrial-scale production of gene therapy DNA vectors | |
CN114807172B (en) | Salt response corn functional gene | |
CN114456244B (en) | Gene OsR49841018986900.01 and application of encoded protein in regulation of rice chalkiness | |
CN112480219B (en) | Sip1Aa soluble insecticidal protein mutant | |
CA1310923C (en) | Dna encoding [asp --] and [lys -, asp --] thaumatin i | |
JPH0829100B2 (en) | A novel hybrid Bacillus thuringiensis gene plasmid and transformed Pseudomonas fluorescens | |
CN108794609B (en) | Chlorophytum comosum root nitrate transport protein CcNPF8.1 and coding gene and application thereof | |
LU501420B1 (en) | Bacillus sj110 strain, insecticidal protein, vip3-like insecticidal gene, and use thereof | |
CN112940135A (en) | Fusion protein, amino acid sequence, coding nucleotide sequence, preparation method and application thereof | |
CN108822218B (en) | Fusion protein of spider toxin peptide and bacillus thuringiensis insecticidal crystal protein and application thereof | |
CN103103204A (en) | Bt cry54Ab1 operon gene, protein encoded by gene and application of gene or protein | |
CN103525835A (en) | Bt Cry71Aa1 gene and coded protein thereof and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |